Skip to main content

Table 1 Clinical characteristics and outcomes

From: The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections

Characteristics and outcomes CVC retained for more than 7 days since bacteremia (n = 16) Removed within 7 days of bacteremia (n = 16) Exchanged with antibiotic-coated catheters within 7 days of bacteremia (n = 8) p-value  
  N (%) N (%) N (%)   
Median age (years), (range) 52 (12–74) 62 (4–83) 55 (29–67) 0.24  
Gender, male 10 (62.5%) 8 (50.0%) 2 (25.0%) 0.28  
Type of cancer     > .99  
  Hematologic malignancy 6 (37.5%) 6 (37.5%) 3 (37.5%)   
  Solid tumor 10 (62.5%) 10 (62.5%) 5 (62.5%)   
Body temperature     0.41  
  ≤ 36°C 2 (12.5%) 0 (0%) 1 (12.5%)   
  36°C −38°C 6 (37.5%) 5 (31.3%) 1 (12.5%)   
  ≥ 38°C 8 (50.0%) 11 (68.7%) 6 (75.0%)   
MIC of vancomycin     0.77  
  < 2.0 9 (56.2%) 9 (56.2%) 3 (37.5%)   
  ≥ 2.0 7 (43.8%) 7 (43.8%) 5 (62.5%)   
Number of lumens of catheters     0.59  
  Single 7 (43.8%) 6 (37.5%) 1 (12.5%)   
  Double 8 (50.0%) 9 (56.3%) 6 (75.0%)   
  Triple 1 (6.3%) 1 (6.3%) 1 (12.5%)   
CVC location     0.22  
  Subclavian 7 (43.8%) 6 (37.5%) 6 (75.0%)   
  Jugular 2 (12.5%) 0 0   
  Basilic 7 (43.8%) 10 (62.5%) 2 (25.0%)   
Defervescence within 3 days of starting antibiotics 11 (68.8%) 14 (87.5%) 6 (75.0%) 0.49  
Relapse within 3 months 2 (12.5%) 0 (0%) 1 (12.5%) 0.4  
Death within 3 months 8 (50.0%) 4 (25.0%) 0 (0%) 0.034 CVC retained vs CVC exchange: p = 0.02
Infection-related death within 3 months 5 (31.3%) 1 (6.3%) 0 (0%) 0.1